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Introduction
The ideal size for the state has always presentedtheoreticians of social politics with difficulties ofdefinition1,2 and recent studies have tended to me-asure this concept as the percentage of public
spending with relation to Gross National Product
(GNP3). For over 20 years now, one sector of world opi-
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Abstract
Objective: To determine the relationship between state size
(measured in terms of public spending) and public health in-
dicators in a sample of countries representing all regions of
the world and from 1990-2000.
Methods: An ecological study was performed using data on
Central Government Spending (CGS) and per capita Gross
National Product (GNP) obtained from the International Mo-
netary Fund, and on life expectancy, maternal, and infant mor-
tality, provided by the World Health Organization. A multiple
linear regression model was fitted to estimate the effect of CGS
on health, which also took into consideration per capita GNP
and geographical region.
Results: CGS varied little over the study period, with con-
vergence around an average of 28%, but within a relatively
wide range (7.80-53.0%); the countries with the strongest eco-
nomies (according to per capita GNP) had the highest levels
of CGS. The influence of this factor was particularly relevant
for the infant mortality rate (r = 0.40; beta = –1.327; EE = 0.237;
t = –5.590; p < 0.001). Per capita GNP and geographic loca-
tion were also associated with variations in health; health in-
dicators tended to be worse for poorer countries in Africa and
Asia. In the adjusted model, CGS was statistically significant
with regard to infant and maternal mortality rates.
Conclusion: The study suggests that state size (in terms of
public spending) has an important influence upon health and
particularly upon mortality. Although it is important to bear in
mind the limitations of this study and the reduced time win-
dow used, these results should be taken into consideration in
the current political and epidemiological debate.
Key words: Health. State. Public spending. Globalization. Eco-
logical study.
Resumen
Objetivo: Determinar la relación entre el tamaño del Esta-
do (medido como el gasto público) y los indicadores de salud
en una muestra de países de todas las regiones del mundo,
en la década de los noventa.
Métodos: Se realizó un estudio ecológico a partir de datos
sobre gasto gubernamental central (GGC) y producto interior
bruto (PIB) per cápita, obtenidos del Fondo Monetario Inter-
nacional, y de esperanza de vida, mortalidad materna y mor-
talidad infantil, de la Organización Mundial de la Salud. Se
construyó un modelo de regresión lineal múltiple, para esti-
mar el efecto del GGC sobre salud, y se introdujo también PIB
per cápita y región.
Resultados: El GGC varía poco durante el período estudiado,
convergiendo alrededor de una media del 28%, pero aún den-
tro de un amplio rango (7,80-53,0%); los países con econo-
mías altas (según PIB per cápita) presentan mayor GGC. Su
efecto tiene especial importancia sobre la mortalidad infantil
(r = 0,40; beta = –1,327; EE = 0,237; t = –5,590; p < 0,001).
También el PIB per cápita y la ubicación regional se asocian
a los cambios en salud, coincidiendo con el empeoramiento
de los indicadores de salud en algunos países pobres de África
y Asia. En el modelo ajustado, el GGC mantiene la asocia-
ción estadística con mortalidad infantil y mortalidad materna.
Conclusión: El estudio sugiere un efecto importante del ta-
maño del Estado sobre la situación de salud, específicamente
sobre la mortalidad. Aunque tienen limitaciones, dada la re-
ducida ventana temporal utilizada, estos resultados deben ser
considerados en el debate político y epidemiológico actual.
Palabras clave: Salud. Estado. Gasto público. Globalización.
Estudio ecológico.
nion has insisted on the need to reduce this ratio in order
to promote more efficient management and improve eco-
nomic performance4. Various international economic or-
ganisms such as the World Bank and the International
Monetary Fund have even incorporated demands for re-
ductions in public spending into their policies5. Other
points of view maintain that the quality associated with
the processes is more important than actual state size6,7.
There are few references in the literature dedicated
to state size, downsizing and the public sector. When
searching the Ecolit, Medline, and Francis data bases
for references to reductions in public sector and health
spending over the past 10 years [(government expen-
diture OR public cost OR public expenditure) AND 
(public sector and health and downsizing)] we found re-
ferences to: the crisis of the Welfare State as a con-
sequence of globalization and its influence upon re-
ductions in the size of the public sector8; the effects of
global changes on employment stability9, and the sen-
sation of insecurity that they produce and their reper-
cussions for health10, and/or for safeguarding health11;
more specific aspects in some works, including the im-
plications of financial policies and other public sector
spending cuts on health service reform in some coun-
tries12,13, and on the mechanisms implemented by the
institutions themselves to make their spending more ef-
ficient14. Other effects of the reduction of the state’s role
in public medicine referred to its psychological conse-
quences15, gender-related differences16, and its con-
sequences for the labour force, the economy and the
relationship between the public and private sectors17.
Other more general and theoretical analyses looked for
indicators capable of showing the influence of globali-
sation and the liberalization of trade and finance on he-
alth18.
The social sciences and epidemiology should sup-
port the management of public policies, explore con-
nections between health indicators and macroecono-
mic determinants, and provide research results to enable
well-informed decision-making. To date, however, few
have taken into account global factors and their links
with health. We therefore have only a few important ap-
proximations in the financial field, with examples such
as the study carried out by the Commission of Macro-
economy and Health of the World Health Organization19.
In the words of Beck, globalisation corresponds to
“the processes through which sovereign states interact
and, through the actions of trans-national agents and
their respective possibilities, establish a series of diffe-
rent orientations, identities and networks20”. According
to the same author, the world market effectively ousts
or substitutes the political role of the state. This is why
research into public health should advance more along
the lines of searching for indicators capable of relating
changes in the role of the state or its public component
(as a result of globalisation) to changes in health.
It has only been traditional to evaluate the effect of
public and private spending on health, and the same
has also been true of spending on education. Howe-
ver, during the last decade numerous studies have emer-
ged that have sought to investigate the influence of pu-
blic spending on health and expenditure on national
health21,22, its relationship with health sector reforms23,
the development of accounting systems to help impro-
ve the efficiency of health organizations and the health
sector24,25, and how to ensure health26. Nevertheless,
some researchers have found that the impact of public
spending on health is very small in comparison with other
socio-economic factors such as per capita income, ine-
qualities in the distribution of income and levels of edu-
cation27. Very few investigations, however, have related
total state or central government expenditure, or the im-
plications of reducing their global role in the public sec-
tor, to its effects on the health of the population, which
is what we intend to do here. Thus, our desired objec-
tive was to determine the relationship between state size
—as expressed in terms of central government spen-
ding and measured as a percentage of its GNP— and
a series of health indicators for a sample of countries
from various parts of the world, based on data relating
to the final decade of the 20th century.
Methods
An ecological study was carried out that established
country categories that enabled internal comparisons
to be made with respect to central government spen-
ding and per capita GNP (pc GNP) and which facilita-
ted analysis of the behaviour of selected health indicators
for these countries with respect to chosen socio-eco-
nomic indicators and the region.
Population and Sample
For reasons of convenience, a sample of 90 coun-
tries was considered (table 1). These countries repre-
sented all regions of the world and belonged to a group
of countries for which CGS information was available
for the last decade28. The sample included 19 develo-
ped countries (D), 8 in economic transition (ET) and 
63 developing countries; of the latter, 24 were located
in Asia and Oceania (AO), 21 in Latin America and the
Caribbean (LAC), and 18 in Africa (A).
Sources of Information
Data corresponding to CGS and pc GNP were ob-
tained from a report by United Nations experts28 and of-
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ficial statistics provided by the International Monetary
Fund29. The health indicators were obtained from the Uni-
ted Nations Development Program30 and from the World
Health Organization. Data relating to these indicators was
collected for years between 1990 and 2000, although avai-
lability varied from year to year (the years offering the
most complete CGS information were 1990 and 1997).
Data for the respective periods was first obtained for CGS
and then for health.
Indicators
State size was measured from CGS as a percen-
tage of GNP. CGS included not only social expenditu-
re (health, education, social security, pensions, subsi-
dies, etc) but all government expenditure, investment,
and transfers. Other indicators were also taken into con-
sideration, including pc GNP (expressed in American
dollars/ inhabitant/ year) and region, because they cons-
titute potential confounders. 
The region was registered in the study according to
an international classification of countries according 
to their socio-economic conditions within a global
structure, as described in the report made by United Na-
tions experts28. In this way, they were defined as de-
veloped countries, countries in economic transition and
developing countries, with the latter group being further
sub-divided on the basis of geographical location. Spe-
cific indicators were sought to reflect health: life expec-
tancy (expressed in years), infant mortality (per 1,000 live
births), and maternal mortality (per 100,000 live births).
Statistical Analysis
With the aid of the SPSS statistics package for Win-
dows, we conducted an exploratory analysis of the pc
GNP and the evolution of CGS as a percentage of GNP.
The latter variable was measured in two ways in the
study: as a continuous variable and as a categorical va-
riable. State size, taken as a categorical variable, was
measured by grouping countries according to CGS [ave-
rage, those whose values were close to the average CGS
(28%) ± a standard deviation (11); small, those whose
values were below this range; and large, those with va-
lues above it].
Data were analysed taking into account the whole
period and CGS relationships were estimated with res-
pect to each of the public health indicators (dependent
variables) by means of correlation coefficients and li-
near regression coefficients. Finally, the multiple linear
regression model was applied in order to independently
estimate the effect of CGS on each of the health indi-
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Table 1. Countries Studied According to World Regions, Period 1990-2000
Developed In Economic Transition Asia and Oceania Latin America and the Caribbean Africa
Australia Belarus Bhutan Argentina Botswana
Austria Bulgaria China Bahamas Burundi
Canada Czech Rep. Cyprus Bolivia Dem. Rep. Congo
Denmark Estonia Fiji Brazil Egypt
Eire Hungary India Belize Ethiopia
Finland Lithuania Iran Chile Gambia
France Poland Israel Columbia Ghana
Greece Rumania Jordan Costa Rica Kenya
Iceland Kuwait Dominican Rep. Madagascar
Luxembourg Lebanon Ecuador Mauritius
Malta Malaysia El Salvador Morocco
Netherlands Myanmar Grenada Namibia
New Zealand Nepal Guatemala Rwanda
Norway Oman Mexico Sierra Leone
Spain Pakistan Nicaragua South Africa
Sweden Philippines Panama Tunisia
Switzerland Rep. Korea S. Vicente and Grenadines Zambia
UK Singapore Trin. & Tobago Zimbabwe
USA Sri Lanka Uruguay
Syria Venezuela
Thailand West Indies
Turkey
Arab Emirates
Yemen
Source: United Nations Organization28.
cators (life expectancy, infant mortality, maternal mor-
tality), making evaluations according to the coefficient
of determination (R2). The pc GNP, CGS, and region were
introduced into the model according to the backwards
method, being entered as continuous variables; the re-
gion was transformed into 4 dummy variables due to
its qualitative condition, with the condition of the most
developed region (D) being compared with each of the
others. Finally, the performance of the health indicators
was analysed, with comparisons being made by groups
of countries, according to state size categories within
each of the regions.
In all cases in which the multiple linear regression
models were adjusted, the assumptions and conditions
of the regression were evaluated on the basis of an
analysis of residuals, as were normality, linearity, ho-
mocedasticity, and non-auto correlation. These requi-
rements were fulfilled in the majority of cases, except
that of life expectancy, for which it was necessary to carry
out logarithmic transformations, although the effects sho-
wed little variation. The ANOVA regression test was also
applied (see statistics in results). 
Results
Descriptive Analysis
Table 2 presents a summary of data relating to the in-
dicators studied in the 90 countries selected. Extreme va-
lues for the health indicators analysed in the study period
ranged from 3 (Sweden, Switzerland) to 180 (Sierra Leone)
for infant mortality, with an average of 39 per 1,000 live
births and from 1 (Greece) to 1,800 (Tunisia) for mater-
nal mortality, with an average of 216 per 100,000 live births.
Life expectancy oscillated between 37 (Sierra Leone) and
79 (Sweden) years, with an average of 67 years.
CGS converged, at the end of the period, towards
an average value of 28% (s = 10.3; cv = 36.8%), but
there was still a wide range (7.8-53.5%) from country
to country. Within the decade studied, extreme values
ranged from 5.7% for Sierra Leone to 69.3% for Kuwait.
The countries with some of the highest CGS values
(more than 50%) included France, Bulgaria, the Net-
herlands, and Hungary; those with the lowest (less than
10%) included Nicaragua, China, Columbia, Myanmar,
Guatemala, and the Republic of Congo.
There was a statistically significant relationship
between CGS and the region, with a different state size
being obtained for rich countries and a smaller one for
poorer countries. On examining the respective econo-
mies on the basis of pc GNP, it was found that the coun-
tries with the highest indexes of wealth also had the gre-
atest CGS values.
The differences between countries with respect to pc
GNP were considerable, with values ranging from a mi-
nimum of 97 dollars in the Democratic Republic of Congo
to a maximum of 28 114 dollars in Switzerland: the ave-
rage value for the whole study period was 5,717 dollars.
Relationship Between Socioeconomic Indicators and Health
A relationship was found between the independent
variables; CGS and pc GNP and the health indicators.
In a primary exploration, employing simple correlations,
changes in health were assumed to show a greater re-
lationship with pc GNP than with CGS, although both
showed a certain degree of correlation. 
On applying the simple linear regression model to
the aggregate data from the study period, statistically
significant relationships were revealed (p < 0.001) bet-
ween CGS and the indicators of life expectancy (r = 0.30;
beta = 0.283; EE = 0.069; t = 4.120), infant mortality 
(r = 0.40; beta = –1.327; EE = 0.237; t = –5.590) and
maternal mortality (r = 0.27: beta = –8.088; EE = 2.419;
t = 3.343).
On adjusting the multiple linear regression models
(table 3), we observed that the three explanatory va-
riables (CGS, pc GNP, and region) showed a significant
linear relationship for infant mortality (p < 0.01). The in-
fluence of the region only proved highly significant when
comparing developed countries to African countries. On
adjusting the effects of the explanatory variables for ma-
ternal mortality, associations of pc GNP, and CGS with
respect to the region remained significant (for develo-
ped countries compared with Africa) within the model
(p < 0.01)
. 
For life expectancy, the coefficient of deter-
mination for the complete model was the highest ob-
tained in the study, but the CGS effect was lost (non-
significant coefficient), while the pc GNP effect and region
effect persisted (comparing developed and African coun-
tries). Figure 1 compares the health indicators, accor-
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Table 2. Behaviour of the Indicators Studied in 90 Countries,
1990-2000
CGSa Per Capita Infant Maternal Life 
GNPb Mortalityc Mortalityd Expectancye
Average 28 5,717 39 216 67
Standard 
deviation 11 7,573 37 348 11
Minimum 6 97 3 1 37
Maximum 69 28,114 180 1,800 79
aCentral Government Spending as a percentage of Gross National Product.
bGross National Product per capita (in USA dollars/inhabitant/year).
cInfant Mortality Rate = deaths of children under one year old for every 1,000 live
births.
dMaternal mortality rate = maternal deaths for every 100,000 live births.
eLife Expectancy = expectation of life at birth, in years.
ding to their regions and state sizes, aggregated for the
period 1990-2000. Additionally, the study suggests a clo-
ser relationship between CGS and the health indicators
in the poorest countries.
Discussion
In most countries the values fluctuate between 10%
and 40% of GNP: these data coincide with those of World
Bank5 and the Inter-American Development Bank31. The
most interesting aspect is the tendency for convergen-
ce with the world average observed in all regions, alt-
hough the relationship between state size and region
is maintained, with this being greatest in the rich coun-
tries and smallest in the poorest ones. 
Thanks to the multiple relationships of CGS, state
size as examined here suggests important connections
between the state and health, in some cases with in-
teraction with the region to which these countries be-
long and to the distribution of wealth among them, with
obvious disparities, as also shown in other analyses32.
The association between the region and pc GNP with
health coincides with trend previously described in other
analyses33. However, we must add to this the great va-
riability observed between countries, which may pos-
sibly be related to state size. The effect of CGS (linear
regression model) is particularly important for infant mor-
tality, although it also demonstrates a high degree of as-
sociation with infant mortality. 
In the multiple linear regression model adjusted for
pc GNP and region (table 3), it is much easier to ob-
serve the effect of state size on health: the increase in
CGS is related to an increase in life expectancy and to
a decrease in infant mortality and maternal mortality,
with the greatest change being associated with the lat-
ter indicator, which is also statistically significant, as in
the case of infant mortality. Apart from other possible
analyses, this finding alone should prompt us to re-
commend actions aimed at improving government
spending destined to promotion of impacts favourable
to health indicators.
Nevertheless, the data presented in figure 1 show
a somewhat paradoxical effect in the countries with the
largest state size (developed countries and countries
in the process of economic transition): here life expec-
tancy shows a non-linear relationship with state size,
with it being lower in larger states than in those of ave-
rage size. This may suggest, on the one hand, that an
increase in state size does not have a uniform effect on
the health indicators in all regions, and on the other, that
there may be an optimal state size, beyond which he-
alth conditions may be negatively affected. Furthermore,
a more favourable relationship between state size and
health can be observed in the poorest regions (in the
case of infant mortality in African countries and mater-
nal mortality in developing countries).
Nevertheless, it should be borne in mind that state
size not only includes within its structure a number of fac-
tors such as education, health, and social security, which
have been positively associated with health, but also mi-
litary expenditure and other factors which may be coun-
terproductive or may even confuse the analysis.
Other investigators have attacked the unfavourable
effects of reductions in state spending on economic, fi-
nancial, and health aspects, countering that it is pos-
sible to achieve economic growth even when maintai-
ning policies of equity and parity34,35. Other authors
conclude that if countries reduce their public spending
they damage their basic indicators of health and edu-
cation, associating these changes with the politics of glo-
balization36-38. In this sense, other investigations—which
like the present research—also explore the indirect im-
plications of globalization, state size and the influence of
the Welfare state on health, and which—as some have
already done—identify links between other sectors of 
welfare and macro economy, will eventually prove im-
portant39.
In summary, there is reason to affirm that state size
is important, as opposed to the aphorism that “a mini-
mal state is the biggest state that can be justified40”. For
other authors, the state is the main collective agent 
for guaranteeing social well-being, for ensuring equity
of access to services and for overcoming the obstacles
that impede this41-43; although its effectiveness in resol-
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Table 3. State Size and Health in 90 Countries (1990-2000). Linear Regression Models 
Adjusted for Per Capita Gross National Product and Region
Model*
Indicator
Coefficient of Association (B) Coefficient of Determination (R2)
Infant mortality, per 1,000 live births –0.795 · GGCa R2 = 0.590 (DW = 1.8; F= 73.419; p < 0.001)
Life Expectancy, years +0.110 · GGC R2 = 0.632 (DW = 1.341; F = 53.309; p < 0.01)
Maternal mortality, per 100,000 live births –5.695 · GGCa R2 = 0.394 (DW = 1.847; F = 16.899; p < 0.001)
aThe coefficients marked in the model are statistically significant, p < 0.01. CGS indicates Central Government Spending.
ving problems relating to the economy and society is not
solely dependent on its size. Research into health may
shed more light on currently undiscovered relationships
between the dimensions of the state and social and he-
alth indicators and thereby help to resolve some of the
political disagreements that still persist with respect to
this question.
The present study has certain limitations such as the
reduced time window and the fact that it did not take
into account certain other variables that can influen-
ce the use of public resources, such as the payment of
the external debt. Similarly, it was not possible at this
stage of the study to consider the typology of the sta-
tes considered: this is undoubtedly a factor that condi-
tions their size and influences upon health and develop-
ment. In order to establish a more precise relationship
between public spending and health indicators, in the fu-
ture, it will be necessary to consider a longer time period.
There is not sufficient data available for countries con-
sidered with reference to the basic indicators, nor for
all the years considered. This is a consequence of a com-
bination of poor recording and/or problems of availabi-
lity, even when the data in question comes from official
sources. This situation, which is particularly dramatic
in the case of maternal mortality44, could have had a
certain affect upon the results obtained.
Furthermore, it cannot be ignored that studies
based on national averages often mask many impor-
tant regional and sub-regional disparities within coun-
tries, particularly with regard to gender, ethnic group,
social capital, social class, and income. These factors
need to be studied in greater depth. Likewise, it is to
be hoped that by breaking data down into still finer de-
tail, for example internally by regions or sub-national re-
gions, it should be possible to discover other kinds of
relationships between government spending and health
which perhaps remain hidden in the present study. The
exclusion from this study of some countries from the for-
mer socialist bloc such as Cuba and Russia may have
negatively influenced the results obtained, reducing the
expected effect in favour of the hypothesis, as they are
large states with, traditionally good health indicators. 
In conclusion, the estimated correlations reflect an
important influence of state size upon health, whether
analysed independently or adjusted for other variables.
In spite of the evident inter-relationships between go-
vernment spending, pc GNP and the region, the multi-
ple linear regression model showed the relationship bet-
ween state size and health indicators. However, this
conclusion needs to be verified by further social rese-
arch and needs to be put to good use in order to en-
rich the current political and epidemiological debate.
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